IP Library Granted Patent US 6,855,345
Granted Patent B2
US 6,855,345 · App. 10/286,167 · Granted Feb 15, 2005

Preventative and treatment effects of Morinda citrifolia on diabetes and its related conditions

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 6,855,345
App. No.
10/286,167
Granted
Feb 15, 2005
Kind
B2
Abstract

The present invention features a unique, natural formulation and method of administering the same to treat and prevent diabetes, or rather advances treatment of diabetes, by providing a naturaceutical composition or treatment formulated with one or more processed Morinda citrifolia products as derived from the Indian Mulberry plant. The Morinda citrifolia is particularly adapted to treat Type II diabetes. The Morinda citrifolia product is preferably a leaf extract, but may also be in the form of a juice, a puree juice, a dietary fiber, or other similar forms and is incorporated into various carriers or naturaceutical compositions suitable for in vivo treatment of a patient. The naturaceutical may also combine other food products into the naturaceutical, such as fruit juices, dietary supplements, vitamins and minerals, and others.

Claims (19)

1. A method for treating diabetes comprising the steps of:

obtaining a processed Morinda citrifolia leaf ethanol extra comprising the steps of:

freezing one or more Morinda citrifolia leaves;

defrosting said Morinda citrifolia leaves;

chopping said Morinda citrifolia leaves into small pieces;

adding an identified amount of distilled water to said Morinda citrifolia leaves to obtain a solution;

agitating said solution at an identified temperature for an identified period of time;

extracting said solution for an identified period of time;

removing any solids in said solution;

extracting ethanol from said solution under decreasing pressure;

filtering any solids produced to obtain a supernatant solution;

freeze-drying said supematant solution to obtain said processed Morinda citrifolia leaf ethanol extract;

preparing a naturaceutical formulation comprising said processed Morinda citrifolia leaf ethanol extract; and

administering said naturaceutical to a patient diagnosed with diabetes.

2. The method of claim 1 , wherein said naturaceutical formulation further comprises a Morinda citrifolia leaf hot water extract.

3. The method of claim 1 , wherein said naturaceutical formulation further comprises a Morinda citrifolia leaf steam distilled extract.

4. The method of claim 1 , wherein said naturaceutical formulation further comprises Morinda citrifolia fruit juice selected from dilute and concentrate form.

5. The method of claim 1 , wherein said naturaceutical formulation further comprises Morinda citrifolia puree juice selected from dilute and concentrate form.

6. The method of claim 1 , wherein said naturaceutical formulation further comprises Morinda citrifolia dietary fiber.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 5, 2007
From: MORINDA, INC.
To: TAHITIAN NONI INTERNATIONAL, INC.
Reel/Frame 018851/0222 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 11, 2003
From: JENSEN, CLAUDE JARAKAE; PALU, AFA KEHAATI; OHISHI, HIFUMI; TANI, HISANORI
To: MORINDA, INC.
Reel/Frame 013752/0718 →